expression profiling; secreted protein, acidic, and rich in cysteines; immunohistochemistry CHRONIC PANCREATITIS (CP) is a disease often diagnosed years after the occurrence of first symptoms (1) . Therefore initial events of inflammation and subsequent fibrosis are not well understood and are still under investigation (23) . Using DNA array technology, Friess et al. (16) reported 157 genes that were upregulated in tissue specimen from patients with CP. In an experimental mouse model induced by Coxsackievirus B4, chronic pancreatic inflammation and fibrosis were reported. Microarray data suggested a concerted upregulation of several hundred genes, including fibrotic and inflammatory genes. As these data represent a pool of time points after infection, the onset of transcript changes remains unclear (30) . To better understand the temporal development we investigated chronic inflammation and fibrosis in an animal model of CP [WistarBonn/Kobori (WBN/Kob) rat].
The WBN/Kob rat spontaneously develops chronic pancreatic inflammation and does not require any intervention or manipulation. The establishment of the disease is fairly synchronous (29) . In this model, pancreatic acinar damage leads to attraction of neutrophil granulocytes and macrophages. The initially "acute" inflammatory state progresses to a chronic phase with the destruction of the parenchyma and fibrosis. Tissue structure destruction is characterized by bleeding and the activation of pancreatic stellate cells. Finally, the remodeling of the acinar compartment also affects islets resulting in diabetes. Concurrent with the destruction of acinar cells, is the formation of tubular complexes that represent a form of acinarto-duct metaplasia (29) . This model therefore presents the opportunity to test hypotheses concerning the reaction of the pancreatic acinar cells toward inflammatory cells, as well as toward profibrotic stellate cells and tumor metaplasia. As we presented in earlier reports, chronic pancreatic inflammation can be suppressed by COX-2 inhibitors and by COX-2-dependent inhibition of macrophage infiltration (34, 39) .
One of the proteins reportedly involved in tissue remodeling is secreted protein, acidic, and rich in cysteines (SPARC), also named osteonectin (ON) and BM40 (basement membrane tumors), belonging to the family of matricellular proteins. This 43 kDa glycoprotein is known to be expressed in bone matrix (41) as ON and during embryonic bone formation (28) . It is expressed in numerous tissues, especially in damaged tissues where extracellular matrix (ECM) remodeling is necessary in response to injury, e.g., in skin and numerous other organs (13) and is highly associated with malignant melanomas (32) . An increase of SPARC has also been reported for human chronic pancreatitis (6, 16) and pancreatic cancer (6, 15, 27) .
There are some controversial findings for SPARC, as expression levels are depending on the organ or cell lines or even the size of the damage of the wounds (3, 9) . SPARC is localized in the ECM, and it appears to interact with collagen and regulates its deposition (35) . Upregulated expression of SPARC is often associated with fibrosis, silencing SPARC with siRNA reduced collagen expression and fibrosis (43) . This spawned the interest in the role of SPARC in various fibrotic tissues, in diseases such as scleroderma, or during fibrotic scarring in organ healing. SPARC is not restricted to the ECM; this protein also resides in the cytoplasm and the nucleus, where it may act as an inhibitor of DNA synthesis (25) . In addition, differential promoter methylation and glycosylation of SPARC might be responsible for different functional roles in vivo (20) . To verify the cellular expression of SPARC to acinar cells, we used PSP (pancreatic stone protein) (12) , a well-characterized secretory protein that is a member of the regenerating protein/pancreatic secretory stress protein family (21) . These proteins are secreted into the centroacinar duct and are part of the pancreatic juice. They are characteristically increased under stress or inflammation (5, 18) .
In this report we analyze genes representing major events governing inflammation and tissue remodeling. We identified genes induced during chronic pancreatic inflammation. We focused on the expression and localization of ECM proteins known to be involved in wound healing and correlated to fibrogenesis. We could demonstrate the localization of SPARC in acinar cells in the vicinity of inflammatory foci.
MATERIALS AND METHODS
Animal husbandry and samples. Animal husbandry was conducted according to institutional guidelines and approved by the Veterinary office of Kanton Zurich.
Animal husbandry, times of death, and RNA extraction were as described previously (5, 17) . In short, male WBN/Kob rats are Wistar rats that spontaneously develop chronic pancreatic inflammation between the ages of 12 and 16 wk, probably due to a genetic defect. The weight development of both WBN/Kob and Wistar rats is given in Supplemental Fig. S1 . 1 mRNA samples from an experiment with cerulein-induced acute pancreatitis were prepared as described earlier (18) .
Human samples. In this study, we evaluated specimens resected from patients who underwent surgery at the University Hospital Zurich, Switzerland, and conforming with the Helsinki protocol. Our human and animal protocols were reviewed and approved by the Ethics Committees of the University Hospital Zürich and the Canton of Zürich.
Microarrays. Three animals per strain and time point were tested. Subsequent production of cRNA followed the recommendation of Affymetrix. Briefly, five micrograms of purified total RNA were reverse transcribed into double-stranded cDNA in the presence of an oligo dT-primer (Microsynth, Balgach, Switzerland) with a T7 RNA polymerase (Superscript Double-Stranded cDNA synthesis kit, Invitrogen). Purified double-stranded cDNA was in vitro transcribed into cRNA in the presence of biotin-labeled nucleotides using the High Yield Transcription kit (Enzo Biochemical, New York, NY). We fragmented and hybridized 15 g of purified biotin-labeled cRNA onto Affymetrix RG_U34A GeneChip Arrays. Thirty of the GeneChips were from the same lot; two were from a different lot, but all were of the same design and probe array. Their signals of the positive and negative controls did not differ from the larger lot. Hybridizations were carried out for 16 h at 65°C in presence of Affymetrix Eukaryotic Hybridization controls, B2 control oligonucleotides, 0.1 mg/ml herring sperm DNA and 0.5 mg/ml acetylated BSA included in the hybridization buffer. Microarrays were then washed on the Affymetrix Fluidics Station FS400 and stained with phycoerythrinstreptavidin, according to the manufacturer's instructions. Fluorescent images and hybridization intensities were acquired and processed by Agilent Gene-Array Scanner 2500 (Agilent, Palo Alto, CA) using Affymetrix Microarray Suite 5.0 software.
Evaluation and statistics of the results of the microarrays. To quantify gene expression from GeneChip array data, the normalization method, probe measure and summary scheme as implemented in the dCHIP software (26) was used. Briefly, for each gene of the Wistar rats, all time points were averaged. This average was then used to normalize all data points (time and strain). Therefore, the data indicate changes over time and strain differences. The raw data are provided via link as .CEL files and alternatively as processed data (expression values) in Excel spreadsheets. We reduced initial data dimensionality by performing a covariance analysis between the different conditions. To find statistically significant changes in gene expression within the different age and strain treatments, two-way ANOVA was used as implemented in Genespring 7.1. The false discovery rate was controlled at a level of P ϭ 0.05 using the method from Benjamini and Hochberg (4) (false discovery rate controlling method). Applying ANOVA analysis with a P value of 0.05 without any multiple testing corrections would include several hundred false positives. In contrast, controlling the false discovery rate at a level of P ϭ 0.05 greatly reduces the number of false positives (4).
We then transferred elected genes to GeneGo software for analysis of interaction network and categorized them by comparing the gene list of selected genes with the lists of genes grouped according to the Gene Ontology Slim (GO Slim) classification. Using a standard Fisher's Exact test, we compared the number of overlapping genes between the list of selected genes and the respective GO Slim gene lists with the occurrence of such overlap by chance, considering the total number of genes in the genome and the number of genes in each respective gene list.
Supplementary raw .CEL data files as well as dCHIP processed and normalized expression values can be downloaded from GEO (www.ebi.ac.uk/aerep/login, user name: E-MEXP-1704).
Immunohistochemistry. Rat and human pancreatic tissue specimens were selected, fixed in buffered 4% formalin (36 h), and embedded in paraffin as previously described (18) . Sections (4 -5 m thick) were deparaffinized in xylene and rehydrated through a graded ethanol series. To unmask PSP/reg and SPARC, double immunofluorescence labeling for SPARC and PSP/reg was not feasible, since the two antigens required two different retrieval protocols. Therefore, conventional chromogens were used in the following order: proteinase K digestion to stain for SPARC (DAB, brown) followed by microwave treatment for PSP/reg (fuchsine, red).
To unmask SPARC, sections were blocked by incubation in methanol containing 0.3% H2O2 for 30 min at room temperature (RT), washed in a Tris buffer solution (0.17 M NaCl, 0.005 M Tris, pH 7.5) that was used for all dilutions, as well as for all washing steps, treated with 0.04 mg/ml proteinase K in Tris/0.05% Tween for 20 min at 27°C, and washed with Tris again. The Vectastain ABC kit (Vector Laboratories, Burlingame, CA) was used for immunostaining, and the supplier's recommendations were observed. Nonspecific binding sites were blocked with "normal goat serum" (provided with the kit) diluted 1:20 in Tris/1% BSA/0.05% Tween (O/N, 4°C). The blocking solution was replaced by SPARC (AON-1) primary monoclonal antibody (Developmental Studies Hybridoma Bank, see ACKNOWLEDGMENTS), diluted 1:200 in blocking solution, and incubated for 2 h at RT.
Incubations with the biotinylated secondary anti-mouse IgG antibody and the ABC reagent were performed as recommended. Staining with DAB chromogen (DAKO) was stopped after 3 min.
Double immunostaining for SPARC and PSP. The double staining for SPARC and PSP/reg was carried out as follows: After labeling for SPARC was accomplished, sections were immersed in 0.01 M tri-Nacitrate, pH 6.0, and brought to boiling temperature in a microwave oven (15 min). After reaching RT again, the slides were rinsed in Tris, and nonspecific binding sites were blocked again with "normal goat serum" (O/N, 4°C). The blocking solution was replaced by rabbit anti-rat PSP/reg serum (38) . The secondary antibody, an anti-rabbitIgG alkaline phosphatase (SIGMA, Switzerland) was incubated for 2 h at RT followed by development with fuchsine. The sections were then counterstained with hematoxylin, dehydrated, and embedded in Histomount as recommended by DAKO.
RNA extraction and real-time polymerase chain reaction. RNA was extracted and used for real-time polymerase chain reaction (PCR) as described previously (5) . The primers were from Applied Biosystems, and the inventoried gene expression assays for SPARC (Rn00561955_m1), serine (or cysteine) peptidase inhibitor (SERPIN) H1 (Rn00567777_m1), tissue inhibitor of metallopro-teinase (TIMP) 1 (Rn00587558_m1), TIMP2 (Rn00573232_m1), collagen I␣1 (Rn01463848_m1), collagen III␣1 (Rn01437683_m1), matrix metalloproteinase (MMP) 14 (Rn00579172_m1), and fibronectin 1 (Rn00569575_m1) have been used.
Real-time PCR was run on a Taqman 7000 (Applied Biosystems, Switzerland) under standard conditions. Transcript levels were quantified using 18S RNA (Applied Biosystems) as a reference and normalized.
RESULTS

Microarray analysis of WBN/Kob rat pancreas.
To analyze changes in gene expression during chronic inflammation in the pancreas of WBN/Kob rats, we killed animals at week 6, 9, 12, 16, 24 , and 36 and compared them with age-matched Wistar rat pancreas. As shown in Fig. 1 , WBN/Kob rats exhibited numerous genes which were significantly upregulated at week 16 and later, with a P value Ͻ0.05 as assessed by the false discovery rate method. This points to a highly inflammatory process in the WBN/Kob rats compared with healthy Wistar rats visible in the clustering profile (Fig. 1) . These up-and downregulated genes are also as shown in Supplemental Fig. S2 and the corresponding data (Supplemental Table S1 ). Table 1 depicts those 20 genes that were upregulated by a factor 9 or more, e.g., CD74, biglycan, or collagen.
The data from the microarray results were then transferred to GeneGo. They revealed several pathways that were significantly activated. We investigated the most significantly activated pathways and focused on "ECM remodeling through cell adhesion" pathway to show genes involved in fibrogenesis and transdifferentiation of pancreatic tissue (Fig. 2) .
Verification of microarray results. To establish whether the microarrays are representative and reflect pancreatitis, we tested a gene known to be upregulated during the development of chronic pancreatitis. PAP (22) is upregulated in the acinar cell on protein and mRNA levels in experimental acute (19) and chronic pancreatitis (5) (data not shown). Furthermore, these mRNA levels parallel PAP levels determined previously in tissue homogenate by quantitative ELISA. To verify the results from the microarray analysis, we quantified selected transcript levels for genes identified by the GeneGo ECM remodeling pathway. Figure 3 demonstrates significant upregulation for SPARC, SERPINH1, TIMP1, TIMP2, collagen I␣1, collagen III␣1, MMP14, and fibronectin mRNA both on the microarray data and validated by RT-PCR. In the supplemental data, we also provide examples of other pathways that are affected by the inflammatory process e.g., cytoskeleton rearrangement and the complement system.
Localization of SPARC during inflammation. From the microarray transcript analysis, we identified SPARC with a significant upregulation during the phase of inflammation. Therefore we tried to localize this protein, which has been implicated in tissue repair in pancreatic sections. As shown in Fig. 4 , SPARC is highly expressed in intact acinar tissue of chronic pancreatic inflammation in 16 wk old WBN/Kob rat (Fig. 4 , A and C-I) and human CP (Fig. 4, J-L) . Figure 4B shows SPARC expression in a healthy age-matched Wistar control rat.
In rats, SPARC is highly expressed along the basal membrane of acinar cells, while PSP is localized predominantly to Fig. 1 . Gene clusters as identified by 2-way ANOVA for time and strain parameters with the false discovery rate controlling method, at least 2-fold changes (red is upregulated; blue is down regulated) and P Ͻ 0.05. the zymogen granules and apical side of the acinar cells (Fig.  4, A and C) . Healthy Wistar rats also produce SPARC at the basal membrane of acinar cells (Fig. 4B ), but to a lesser extent than in CP (Fig. 4A) . Figure 4D shows high expression in acini but not in islets, compared with the negative control without primary antibody in Fig. 4E . The same is seen in Fig. 4 , G and H, but this part of the pancreas shows impressive differences in the destruction of adjacent lobes. While on the left side of Fig.  4G almost all acini are destroyed and with a loss of SPARC, the adjacent lobes in the middle are still producing SPARC, yet the acinar lobes appear partially dissolved compared with intact tissue in Fig. 4D . Figure 4 , C and F, shows costaining of PSP (red) and SPARC (brown). The brown lining around the intact acini represents the basal staining of SPARC, while PSP fills the acinar space toward the middle of the acini. Again, the expression of both proteins signals the activated state of pancreatic tissue in chronic pancreatic inflammation. Figure 4I demonstrates a higher magnification of pancreatic inflamed tissue in WBN/Kob rats. The arrowhead points to the tubular structures emanating from acini between more or less intact acinar cells that are still producing SPARC and PSP.
To test whether in human CP SPARC is also localized to the basal portion of acinar cells, we tested samples of CP patients (Fig. 4, J-L) . The same transdifferentiation of acinar cells toward tubular formation is seen in human pancreatic tissue. Human chronic pancreatic tissue exhibited expression of SPARC predominantly in acinar cells (Fig. 4J) . Colocalization of SPARC with PSP confirmed this observation (Fig. 4, K and L) .
In pilot experiments we were not able to detect SPARC mRNA by real-time PCR in AR42J, a pancreatic adenocarcinoma cell line. This prompted us to use these cells for evaluation of our immunohistochemistry protocol, to verify that the protein levels were also low in AR42J cellblock sections. We found very weak immunoreactivity particularly when cells are in close contact, but hardly any labeling was found in separated cells (data not shown). We conclude that intraacinar localization of SPARC was not due to background staining in tissue sections.
The detection of SPARC appears to be dependent on the treatment of sections prior to staining. Nuclear and cytosolic localization may not be possible with the same technique. Therefore, we tested different retrieval techniques. Figure 4 , M and N, represents the results of differently pretreated tissue of the rat pancreas. While in Fig. 4 , A-L, the sections were pretreated with proteinase K, sections in Fig. 4 , M and N, were pretreated by 15 min boiling in Na-citrate buffer in a microwave oven. Figure 4M shows staining in the nuclei but no more in cytoplasm. Figure 4N represents the control where no primary antibody was loaded. Finally in Fig. 4O pretreatment was omitted, and no staining could be found.
From these experiments, we conclude that acinar cells exhibit an increased expression of SPARC in the early phase of pancreatic inflammation and nuclear localization is observed in several cell types.
Is SPARC inflammation dependent? From our observation that SPARC was upregulated in acinar cells in the vicinity of inflammatory loci, we asked whether SPARC would still be expressed in the WBN/Kob rat pancreas, when the spontaneous tissue damage was not removed but inflammation was suppressed. As shown in Fig. 5A , we determined Columns indicate common gene name, fold change, P value, and gene bank accession number. Nonidentified genes, e.g., expressed sequence tags, were omitted. mRNA levels of SPARC by real-time PCR in WBN/Kob rats treated with an anti-inflammatory drug (Vioxx) as described in Reding et al. (34) . Indeed, SPARC exhibited a significant reduction in Vioxx-treated rats, suggesting that it is only activated or synthesized during inflammation. Concurrently, ␣-smooth muscle actin (SMA) was high in fibrotic tissue of untreated WBN/Kob rats, while in the Vioxx-treated rats the reduction of fibrosis was demonstrated by a significantly lower expression of ␣-SMA.
In a further experiment, we tested whether SPARC was induced during acute, cerulein-induced pancreatitis as described in Graf et al. (18) , where inflammation is dominated by edema and a moderate recruitment of inflammatory cells. As demonstrated in Fig. 5B , saline injection or injection of a physiological dose of cerulein did not cause an increase in SPARC, while a supramaximal dose caused a significant increase. Since SPARC has been observed in the profibrotic stellate cells, ␣-SMA, a marker for stellate cell activation, was tested. No increase was observed, suggesting that stellate cells were not activated and that SPARC was derived from acinar cells and/or inflammatory cells.
DISCUSSION
During development of chronic pancreatic inflammation, a number of genes are clearly and significantly up-or downregulated. In this paper we demonstrate massive upregulation of many genes involved in inflammation and the acinar response to inflammation. Furthermore, SPARC, an ECM remodeling protein, is transiently upregulated and subsequently lost in the final stages of acinar destruction.
Genes like PAP and SPARC are upregulated in pancreatic acinar cells. Others are expressed by leukocytes and are "imported" during inflammation, such as cell recognition genes like CD36, CD48, and CD53 (Supplemental Table S1 ). While some genes can be of both stromal and infiltrating cell origin, e.g., TNF-␣, other proteins like SPARC are commonly found in acinar cells (Fig. 4) . The WBN/Kob rat is an excellent model to study chronic pancreatic inflammation. There is a persistent endogenous (genetically determined) damage that leads to acinar stress and inflammation. The synchronicity and penetration are high. Hence, it is possible to study early events leading to infiltration and chronic inflammatory changes. Many genes known to be involved in fibrosis are significantly upregulated (Table 1 and  Supplemental Table S1 ).
The advantage of a temporal profile for each gene and strain is the observation that a significant difference can often not be detected by a single comparison but by assessment of the overall behavior of the individual expression profiles over the measured time points. A two-way ANOVA is particularly appropriate to select genes based on strong interactions of the strain and age effects.
Identification of ECM remodeling network. Analysis of genes upregulated during inflammation led us to study interactions by using very helpful software, GeneGo. This tool provides information on those genes that have proven interactions. By this method we were able to pick out several networks, one of which, the ECM-remodeling pathway, provided a framework that allowed us to analyze fibrotic changes (Fig.  2) . Collagens, MMPs, and TIMPs were selectively upregulated in addition to other genes such as SPARC. In human CP, genes from the same network, including SPARC, were reported upregulated (16) . Some of these overlap with protein patterns shown in pancreatic cancer (15) . In the Coxsackievirus-induced pancreatitis in the mouse, the same genes were upregulated, e.g., SPARC, biglycan, and various collagen isoforms (30) . Interestingly, the two types of virus employed caused either an "acute" or a "chronic" form with a differential gene expression, allowing an assessment of pancreatic repair and regeneration. It would be interesting to determine which genes respond specifically to the virus and which are regulated by pancreatic tissue damage caused by the virus.
The extent of upregulation of SPARC in CP may be an indicator of the tissue remodeling activity. Friess et al. (16) reported a 51-fold upregulation in human pancreatic specimen. Our own data in the rat suggest a similar extent with an increase of ϳ30-fold by RT-PCR. The Coxsackie-driven mouse pancreatitis data do not indicate the extent of regulation. Nevertheless, this consistency of SPARC increase supports the importance of this multifunctional protein, the functions of which still remain to somewhat unclear.
SPARC is involved in development, inflammation, and cancer and seems to be an important key molecule in these processes (14, 28, 31) . However, SPARC protein is ambiguous or is thought to fulfill different functions. In several experimental fields controversial results have been reported, mostly concerning tumor research. SPARC expression is dependent on tissue origin or tumor cell type or also expressed by leukocytes (10, 37) and is either an enhancer or silencer of tumor progres- sion (11) . Therefore, its influence on ECM remodeling, collagen rearrangements, and later on in tumor progression and in its microenvironment is of major interest.
While SPARC has been reported in tumor biology, in wound healing, and in selected patients with CP, this protein has not been investigated during the various phases of disease progression of CP. Here, we present the expression pattern of SPARC and compare it to PSP. We found that both proteins are active in the inflamed tissue. PSP was localized to the zymogen granules and apical part of the acinar cells and secreted into the centroacinar duct. SPARC was expressed along the basal membrane of the acinar cell as expected for a matricellular, ECM remodeling protein. When acinar cells were damaged, SPARC and PSP expression could not be detected.
The expression of SPARC was also lost in acini that exhibit tubular complex formation. This process, also called acinar-toduct metaplasia, appears to include a transdifferentiation of acinar cells to duct-like cells (7, 8) . Our results suggest that within an acinus, cells losing acinar characteristics also lose SPARC and PSP. This was observed both in rat and human tissue specimens, supporting the conclusion that SPARC is derived from acinar cells in the inflammatory state. Furthermore, when an anti-inflammatory drug was used to treat the WBN/Kob rats, SPARC expression was significantly reduced concurrent with the absence of inflammation. This conclusion is also supported in cerulein-induced acute pancreatitis, where an increase of SPARC mRNA was observed while stellate cells were not activated. In the late stages of human CP, the fibrotic tissue shows some SPARC expression in stellate cells as demonstrated in Supplemental Fig. S3 , where we detected SPARC and ␣-SMA by immunohistochemistry.
SPARC is highly associated with malignant melanomas, and its expression correlates in certain tumors with aggressiveness and poor prognosis for the outcome of the disease (14) . In other tumors (24, 36, 40, 42) SPARC is downregulated, and thus every tumor requires selective analysis. Prada et al. (33) showed that SPARC produced exclusively by melanoma, but not stromal cells, influences tumor growth. Others just found it upregulated in stromal cells (40) .
In pancreatic cancer, SPARC has been found to suppress tumor growth and it may do so by enhancing stroma formation and preventing fibroblast activation (10) . In contrast, experiments with SPARC-null mice and orthotopic implanted adenocarcinoma cells inducing pancreatic tumors revealed that the absence of host SPARC in SPARC-null mice enhanced tumor growth and metastases, suggesting that the precise localization of SPARC is important for tumor development (2) . This supports our observation that the occurrence of acinar-to-duct metaplasia is associated with a loss of SPARC.
In summary, we have shown by microarray analysis in an animal model of CP that the expression levels of growth factors and inflammatory and profibrotic genes are significantly upregulated during chronic inflammation and fibrosis. SPARC appears to be regulated in acini by inflammation and the loss of expression of the remodeling protein SPARC in damaged acinar cells might favor acinar-to-duct metaplasia.
